Woodline Partners’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-511,351
| Closed | -$3.89M | – | 696 |
|
|
2022
Q4 | $3.89M | Buy |
511,351
+8,940
| +2% | +$68K | 0.05% | 353 |
|
|
2022
Q3 | $4.11M | Buy |
502,411
+126,403
| +34% | +$1.03M | 0.06% | 335 |
|
|
2022
Q2 | $3.64M | Buy |
376,008
+327,908
| +682% | +$3.17M | 0.06% | 304 |
|
|
2022
Q1 | $674K | Buy |
48,100
+75
| +0.2% | +$1.05K | 0.01% | 502 |
|
|
2021
Q4 | $981K | Sell |
48,025
-86,008
| -64% | -$1.76M | 0.01% | 504 |
|
|
2021
Q3 | $2.99M | Sell |
134,033
-74,035
| -36% | -$1.65M | 0.05% | 338 |
|
|
2021
Q2 | $4.72M | Buy |
+208,068
| New | +$4.72M | 0.09% | 229 |
|